<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">35586059</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>20</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Print">1663-9812</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>13</Volume>
            <PubDate>
              <Year>2022</Year>
            </PubDate>
          </JournalIssue>
          <Title>Frontiers in pharmacology</Title>
          <ISOAbbreviation>Front Pharmacol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Effects of Dexmedetomidine on Immune Cells: A Narrative Review.</ArticleTitle>
        <Pagination>
          <StartPage>829951</StartPage>
          <MedlinePgn>829951</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">829951</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.3389/fphar.2022.829951</ELocationID>
        <Abstract>
          <AbstractText>As we all know, dexmedetomidine (DEX), as a highly selective α<sub>2</sub> adrenergic receptor agonist, exerts sedative, anti-anxiety and hypnotic effects by inhibiting the discharge of norepinephrine neurons in locus coeruleus and GABA-related hypnotic pathways. However, the role of DEX in anti-inflammatory and immune regulation has gradually attracted the attention of researchers in recent years. The α<sub>2</sub> adrenergic receptor is one of the members of the adrenergic receptor family, which is widely present in a variety of immune cells and mediates the biological behavior of the inflammatory immune system. At present, there have been more and more studies on the effects of DEX on immune cells and inflammatory responses, but few studies have systematically explored the anti-inflammatory and immunomodulatory effects of DEX. Here, we comprehensively review the published human and animal studies related to DEX, summarize the effects of DEX on immune cells and its role in related diseases, and propose potential research direction.</AbstractText>
          <CopyrightInformation>Copyright © 2022 Chen, Sun, Lv, Dou, Dai, Sun and Lin.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Rui</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Anesthesia and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Anesthesiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sun</LastName>
            <ForeName>Yan</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Anesthesia and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Anesthesiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lv</LastName>
            <ForeName>Jing</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Anesthesia and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Anesthesiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dou</LastName>
            <ForeName>Xiaoke</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Anesthesia and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Anesthesiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dai</LastName>
            <ForeName>Maosha</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Anesthesia and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Anesthesiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sun</LastName>
            <ForeName>Shujun</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Anesthesia and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Anesthesiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lin</LastName>
            <ForeName>Yun</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Anesthesia and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Anesthesiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>05</Month>
          <Day>02</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Front Pharmacol</MedlineTA>
        <NlmUniqueID>101548923</NlmUniqueID>
        <ISSNLinking>1663-9812</ISSNLinking>
      </MedlineJournalInfo>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">adaptive immune response</Keyword>
        <Keyword MajorTopicYN="N">dexmedetomidine</Keyword>
        <Keyword MajorTopicYN="N">immune cells</Keyword>
        <Keyword MajorTopicYN="N">inflammatory factors</Keyword>
        <Keyword MajorTopicYN="N">innate immune response</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>6</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>11</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>19</Day>
          <Hour>2</Hour>
          <Minute>17</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35586059</ArticleId>
        <ArticleId IdType="pmc">PMC9108424</ArticleId>
        <ArticleId IdType="doi">10.3389/fphar.2022.829951</ArticleId>
        <ArticleId IdType="pii">829951</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>
Alboni S., Cervia D., Sugama S., Conti B. (2010). Interleukin 18 in the CNS. J. Neuroinflammation.
7, 9. 10.1186/1742-2094-7-9
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1742-2094-7-9</ArticleId>
            <ArticleId IdType="pmc">PMC2830964</ArticleId>
            <ArticleId IdType="pubmed">20113500</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Anderson C. D., Lindgren B. R., Andersson R. G. (1987). Effects of Clonidine on the Dermal Inflammatory Cell Response of Experimental Toxic and Allergic Contact Reactions and Intradermal Hypersensitivity. Int. Arch. Allergy Appl. Immunol.
83, 371–376. 10.1159/000234371
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000234371</ArticleId>
            <ArticleId IdType="pubmed">3610350</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Andersson U., Yang H., Harris H. (2018). Extracellular HMGB1 as a Therapeutic Target in Inflammatory Diseases. Expert Opin. Ther. Targets
22, 263–277. 10.1080/14728222.2018.1439924
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/14728222.2018.1439924</ArticleId>
            <ArticleId IdType="pubmed">29447008</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Barbera-Guillem E., Nelson M. B., Barr B., Nyhus J. K., May K. F., Feng L., et al.  (2000). B Lymphocyte Pathology in Human Colorectal Cancer. Experimental and Clinical Therapeutic Effects of Partial B Cell Depletion. Cancer Immunol. Immunother.
48 (10), 541–549. 10.1007/PL00006672
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/PL00006672</ArticleId>
            <ArticleId IdType="pubmed">10630306</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Berkowitz D. E., Price D. T., Bello E. A., Page S. O., Schwinn D. A. (1994). Localization of Messenger RNA for Three Distinct Alpha 2-adrenergic Receptor Subtypes in Human Tissues. Evidence for Species Heterogeneity and Implications for Human Pharmacology. Anesthesiology
81, 1235–1244. 10.1097/00000542-199411000-00018
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/00000542-199411000-00018</ArticleId>
            <ArticleId IdType="pubmed">7978483</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Besedovsky L., Lange T., Born J. (2012). Sleep and Immune Function. Pflugers. Arch.
463, 121–137. 10.1007/s00424-011-1044-0
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00424-011-1044-0</ArticleId>
            <ArticleId IdType="pmc">PMC3256323</ArticleId>
            <ArticleId IdType="pubmed">22071480</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Bhana N., Goa K. L., McClellan K. J. (2000). Dexmedetomidine. Drugs.
59, 263–268. 10.2165/00003495-200059020-00012
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2165/00003495-200059020-00012</ArticleId>
            <ArticleId IdType="pubmed">10730549</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Brady J., Carotta S., Thong R. P., Chan C. J., Hayakawa Y., Smyth M. J., et al.  (2010). The Interactions of Multiple Cytokines Control NK Cell Maturation. J. Immunol.
185, 6679–6688. 10.4049/jimmunol.0903354
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4049/jimmunol.0903354</ArticleId>
            <ArticleId IdType="pubmed">20974986</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Cai Q. H., Tang Y., Fan S. H., Zhang Z. F., Li H., Huang S. Q., et al.  (2017). 
In Vivo effects of Dexmedetomidine on Immune Function and Tumor Growth in Rats with Ovarian Cancer through Inhibiting the p38MAPK/NF-ᴋb Signaling Pathway. Biomed. Pharmacother.
95, 1830–1837. 10.1016/j.biopha.2017.09.086
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.biopha.2017.09.086</ArticleId>
            <ArticleId IdType="pubmed">28968927</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Cardinale F., Chinellato I., Caimmi S., Peroni D. G., Franceschini F., Miraglia Del Giudice M., et al.  (2011). Perioperative Period: Immunological Modifications. Int. J. Immunopathol Pharmacol.
24 (Suppl. 3), S3–S12. 10.1177/03946320110240s302
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/03946320110240s302</ArticleId>
            <ArticleId IdType="pubmed">22014920</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Chai Y., Cao Z., Yu R., Liu Y., Yuan D., Lei L. (2020). Dexmedetomidine Attenuates LPS-Induced Monocyte-Endothelial Adherence via Inhibiting Cx43/PKC-/NOX2/ROS Signaling Pathway in Monocytes. Oxid. Med. Cell. Longev.
2020, 2930463. 10.1155/2020/2930463
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2020/2930463</ArticleId>
            <ArticleId IdType="pmc">PMC7395996</ArticleId>
            <ArticleId IdType="pubmed">32774667</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Chang S. H., Chen D. (2011). Signaling of Interleukin-17 Family Cytokines in Immunity and Inflammation. Cell. Signal.
23, 1069–1075. 10.1016/j.cellsig.2010.11.022
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cellsig.2010.11.022</ArticleId>
            <ArticleId IdType="pmc">PMC3078175</ArticleId>
            <ArticleId IdType="pubmed">21130872</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Chang. Y., Huang. X., Liu. Z., Han. G., Huang. L., Xiong. Y-C., et al.  (2013). Dexmedetomidine Inhibits the Secretion of High Mobility Group Box 1 from Lipopolysaccharide-Activated Macrophages In Vitro
. J. Surg. Res.
181, 308–314. 10.1016/j.jss.2012.07.017
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jss.2012.07.017</ArticleId>
            <ArticleId IdType="pubmed">22939552</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Chaplin D. D. (2010). Overview of the Immune Response. J. Allergy Clin. Immunol.
125, S3–S23. 10.1016/j.jaci.2009.12.980
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jaci.2009.12.980</ArticleId>
            <ArticleId IdType="pmc">PMC2923430</ArticleId>
            <ArticleId IdType="pubmed">20176265</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Chen G., Le Y., Zhou L., Gong L., Li X., Li Y., et al.  (2016). Dexmedetomidine Inhibits Maturation and Function of Human Cord Blood-Derived Dendritic Cells by Interfering with Synthesis and Secretion of IL-12 and IL-23. Plos. One.
11 (4), e0153288. 10.1371/journal.pone.0153288
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0153288</ArticleId>
            <ArticleId IdType="pmc">PMC4824534</ArticleId>
            <ArticleId IdType="pubmed">27054340</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Chen S. L., Zhou W., Hua F. Z. (2016). 
In Vitro effect of Dexmedetomidine on the Respiratory Burst of Neutrophils. Genet. Mol. Res.
15 (2). 10.4238/gmr.15028069
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4238/gmr.15028069</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Cheng. S. S., Lukacs. N. W., Kunkel S. L. (2002). Eotaxin/CCL11 Is a Negative Regulator of Neutrophil Recruitment in a Murine Model of Endotoxemia. Exp. Mol. Pathol.
73, 1–8. 10.1006/exmp.2002.2439
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1006/exmp.2002.2439</ArticleId>
            <ArticleId IdType="pubmed">12127048</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Cho J. S., Seon K., Kim M. Y., Kim S. W., Yoo Y. C. (2021). Effects of Perioperative Dexmedetomidine on Immunomodulation in Uterine Cancer Surgery: A Randomized, Controlled Trial. Front. Oncol.
11, 749003. 10.3389/fonc.2021.749003
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fonc.2021.749003</ArticleId>
            <ArticleId IdType="pmc">PMC8635094</ArticleId>
            <ArticleId IdType="pubmed">34868950</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Cowburn A. S., Condliffe A. M., Farahi N., Summers C., Chilvers E. R. (2008). Advances in Neutrophil Biology: Clinical Implications. Chest
134, 606–612. 10.1378/chest.08-0422
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1378/chest.08-0422</ArticleId>
            <ArticleId IdType="pmc">PMC2827863</ArticleId>
            <ArticleId IdType="pubmed">18779195</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Cruickshank M., Henderson L., MacLennan G., Fraser C., Campbell M., Blackwood B., et al.  (2016). Alpha-2 Agonists for Sedation of Mechanically Ventilated Adults in Intensive Care Units: a Systematic Review. Health Technol. Assess.
20 (25), 1–117. 10.3310/hta20250) </Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3310/hta20250</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Dahl R. (1991). The Eosinophil. Allerg Immunol. (Paris)
23, 429–431. </Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1811647</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Deshmane S. L., Kremlev S., Amini S., Sawaya B. E. (2009). Monocyte Chemoattractant Protein-1 (MCP-1): an Overview. J. Interferon. Cytokine Res.
29, 313–326. 10.1089/jir.2008.0027
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/jir.2008.0027</ArticleId>
            <ArticleId IdType="pmc">PMC2755091</ArticleId>
            <ArticleId IdType="pubmed">19441883</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Dong W., Chen M. H., Yang Y. H., Zhang X., Huang M. J., Yang X. J., et al.  (2017). The Effect of Dexmedetomidine on Expressions of Inflammatory Factors in Patients with Radical Resection of Gastric Cancer. Eur. Rev. Med. Pharmacol. Sci.
21 (15), 3510–3515. </Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28829488</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Elmoutaz Mahmoud. H., Rashwan D. A. E. (2018). Efficacy of Dexmedetomidine versus Ketofol for Sedation of Postoperative Mechanically Ventilated Patients with Obstructive Sleep Apnea. Crit. Care Res. Pract.
2018, 1015054. 10.1155/2018/1015054
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2018/1015054</ArticleId>
            <ArticleId IdType="pmc">PMC5829338</ArticleId>
            <ArticleId IdType="pubmed">29623221</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Ferreira J. A., Bissell Brittany. D. (2018). Misdirected Sympathy: The Role of Sympatholysis in Sepsis and Septic Shock. J. Intensive Care Med.
33, 74–86. 10.1177/0885066616689548
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/0885066616689548</ArticleId>
            <ArticleId IdType="pubmed">28142307</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Flanders C. A., Rocke A. S., Edwardson S. A., Baillie J. K., Walsh T. S. (2019). The Effect of Dexmedetomidine and Clonidine on the Inflammatory Response in Critical Illness: a Systematic Review of Animal and Human Studies. Crit. Care
23 (1), 402. 10.1186/s13054-019-2690-4
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13054-019-2690-4</ArticleId>
            <ArticleId IdType="pmc">PMC6907244</ArticleId>
            <ArticleId IdType="pubmed">31829277</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
García J. J., Carmen Sáez M., De la. Fuente M., Ortega E. (2003). Regulation of Phagocytic Process of Macrophages by Noradrenaline and its End Metabolite 4-Hydroxy-3-Metoxyphenyl-Glycol. Role of Alpha- and Beta-Adrenoreceptors. Mol. Cell. Biochem.
254, 299–304. </Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14674709</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Gu C., Wu L., Li X. (2013). IL-17 Family: Cytokines, Receptors and Signaling. Cytokine.
64, 477–485. 10.1016/j.cyto.2013.07.022
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cyto.2013.07.022</ArticleId>
            <ArticleId IdType="pmc">PMC3867811</ArticleId>
            <ArticleId IdType="pubmed">24011563</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Guo N. H., Shi Q. Z., Hua J. Y., Li Z. J., Li J., He W. F., et al.  (2010). Expression of Regulatory T Cells and Th17 Cells in Idiopathic Thrombocytopenic Purpura and its Significance. Zhonghua Xue Ye. Xue Za Zhi
31, 610–612. </Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21122322</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Guo. F., Ding. Y., Xue Y., Cai. X. (2018). Effect of Dexmedetomidine, Midazolam, and Propofol on Lipopolysaccharide-Stimulated Dendritic Cells. Exp. Ther. Med.
15, 5487–5494. 10.3892/etm.2018.6094
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3892/etm.2018.6094</ArticleId>
            <ArticleId IdType="pmc">PMC5996670</ArticleId>
            <ArticleId IdType="pubmed">29904429</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Huang L., Qin C., Wang L., Zhang T., Li J. (2021). Effects of Dexmedetomidine on Immune Response in Patients Undergoing Radical and Reconstructive Surgery for Oral Cancer. Oncol. Lett.
21 (2), 106. 10.3892/ol.2020.12367
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3892/ol.2020.12367</ArticleId>
            <ArticleId IdType="pmc">PMC7751342</ArticleId>
            <ArticleId IdType="pubmed">33376539</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Inada T., Shirane A., Hamano N., Yamada M., Kambara T., Shingu K. (2005). Effect of Subhypnotic Doses of Dexmedetomidine on Antitumor Immunity in Mice. Immunopharmacol. Immunotoxicol.
27, 357–369. 10.1080/08923970500240883
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/08923970500240883</ArticleId>
            <ArticleId IdType="pubmed">16237949</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Irwin M. R., Opp M. R. (2017). Sleep Health: Reciprocal Regulation of Sleep and Innate Immunity. Neuropsychopharmacology
42, 129–155. 10.1038/npp.2016.148
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/npp.2016.148</ArticleId>
            <ArticleId IdType="pmc">PMC5143488</ArticleId>
            <ArticleId IdType="pubmed">27510422</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Jeong S. I., Shin J. A., ChoS, Kim H. W., Lee J. Y., Kang J. L., et al.  (2016). Resveratrol Attenuates Peripheral and Brain Inflammation and Reduces Ischemic Brain Injury in Aged Female Mice. Neurobiol. Aging
44, 7484. 10.1016/j.neurobiolaging.2016.04.007
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neurobiolaging.2016.04.007</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Joshua E. (2021). Physiology of Sleep. Treasure Island (FL): StatPearls Publishing. </Citation>
        </Reference>
        <Reference>
          <Citation>
Kalbach N., Schaller A., Rosene A., Farley L., Zani K., Saini A. (2019). 1230: Dexmedetomidine to Facilitate Respiratory Support in Pediatric Severe Asthma. Crit. Care Med.
47 (1), 591. 10.1097/01.ccm.0000551974.08011.2a
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/01.ccm.0000551974.08011.2a</ArticleId>
            <ArticleId IdType="pubmed">30855326</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Kallioinen M., Scheinin A., Maksimow M., Långsjö J., Kaisti K., Takala R., et al.  (2019). The Influence of Dexmedetomidine and Propofol on Circulating Cytokine Levels in Healthy Subjects. BMC. Anesthesiol.
19, 222. 10.1186/s12871-019-0895-3
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12871-019-0895-3</ArticleId>
            <ArticleId IdType="pmc">PMC6894489</ArticleId>
            <ArticleId IdType="pubmed">31805854</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Kang B. Y., Won L. S., Sung K. T. (2003). Stimulation of Interleukin-12 Production in Mouse Macrophages via Activation of P38 Mitogen-Activated Protein Kinase by Alpha2-Adrenoceptor Agonists. Eur. J. Pharmacol.
467, 223–231. 10.1016/s0014-2999(03)01628-5
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s0014-2999(03)01628-5</ArticleId>
            <ArticleId IdType="pubmed">12706479</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Kantari C., Pederzoli-Ribeil M., Witko-Sarsat V. (2008). The Role of Neutrophils and Monocytes in Innate Immunity. Contrib. Microbiol.
15, 118–146. </Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18511859</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Keating G. M. (2015). Dexmedetomidine: A Review of its Use for Sedation in the Intensive Care Setting. Drugs
75, 1119–1130. 10.1007/s40265-015-0419-5
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s40265-015-0419-5</ArticleId>
            <ArticleId IdType="pubmed">26063213</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Kennelly R., Conneely J. B., Bouchier-Hayes D., Winter D. C. (2011). Mast Cells in Tissue Healing: from Skin to the Gastrointestinal Tract. Curr. Pharm. Des.
17, 3772–3775. 10.2174/138161211798357854
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2174/138161211798357854</ArticleId>
            <ArticleId IdType="pubmed">22103847</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Kong L., Lu X. H. (2018). Effect of Dexmedetomidine on Perioperative Inflammatory Response and Cellular Immune in Patients Undergoing Radical Operation of Thoracoscopic Lung Cancer. Zhonghua Yi Xue Za Zhi
98 (36), 2929–2932. 10.3760/cma.j.issn.0376-2491.2018.36.011
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3760/cma.j.issn.0376-2491.2018.36.011</ArticleId>
            <ArticleId IdType="pubmed">30293352</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Kurosawa S., Kato M. (2008). Anesthetics, Immune Cells, and Immune Responses. J. Anesth.
22, 263–277. 10.1007/s00540-008-0626-2
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00540-008-0626-2</ArticleId>
            <ArticleId IdType="pubmed">18685933</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Lai Y. C., Tsai P. S., Huang C. J. (2009). Effects of Ddemedetomidine on Regulating Endotoxin-Induced Up-Regulation of Inflammatory Molecules in Murine Macrophages. J. Surg. Res.
154, 212. 10.1016/j.jss.2008.07.010
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jss.2008.07.010</ArticleId>
            <ArticleId IdType="pubmed">19181340</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Lavand'homme P. M., Eisenach J. C. (2003). Perioperative Administration of the Alpha2-Adrenoceptor Agonist Clonidine at the Site of Nerve Injury Reduces the Development of Mechanical Hypersensitivity and Modulates Local Cytokine Expression. Pain
105, 247–254. 10.1016/s0304-3959(03)00221-5
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s0304-3959(03)00221-5</ArticleId>
            <ArticleId IdType="pubmed">14499442</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Lavand'homme P. M., Ma W., De Kock M., Eisenach J. C. (2002). Perineural alpha(2A)-Adrenoceptor Activation Inhibits Spinal Cord Neuroplasticity and Tactile Allodynia after Nerve Injury. Anesthesiology
97, 972–980. 10.1097/00000542-200210000-00033
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/00000542-200210000-00033</ArticleId>
            <ArticleId IdType="pubmed">12357167</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Lee J. M., Han H. J., Choi W. K., Yoo S., Baek S., Lee J. (2018). Immunomodulatory Effects of Intraoperative Dexmedetomidine on T Helper 1, T Helper 2, T Helper 17 and Regulatory T Cells Cytokine Levels and Their Balance: a Prospective, Randomised, Double-Blind, Dose-Response Clinical Study. BMC. Anesthesiol.
18 (1), 164. 10.1186/s12871-018-0625-2
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12871-018-0625-2</ArticleId>
            <ArticleId IdType="pmc">PMC6225705</ArticleId>
            <ArticleId IdType="pubmed">30409131</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Li L. C., Tian Y., Xiao J., Yang Y., Wu J. N., Chen Y., et al.  (2021). Dexmedetomidine Promotes Inflammation Resolving through TGF-Β1 Secreted by F4/80Ly6G Macrophage. Int. Immunopharmacol.
95, 107480. 10.1016/j.intimp.2021.107480
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.intimp.2021.107480</ArticleId>
            <ArticleId IdType="pubmed">33676148</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Li Y., Wang B., Zhang L. L., He S. F., Hu X. W., Wong G. T., et al.  (2016). Dexmedetomidine Combined with General Anesthesia Provides Similar Intraoperative Stress Response Reduction when Compared with a Combined General and Epidural Anesthetic Technique. Anesth. Analg.
122, 1202–1210. 10.1213/ANE.0000000000001165
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1213/ANE.0000000000001165</ArticleId>
            <ArticleId IdType="pubmed">26991622</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Liang Y., Liu H. Z., Wang H. B., Wen X. J., Zhou Q. L., Xu F. (2012). Effects of Dexmedetomidine on Perioperative Cellular Immune Function and Micro-metastasis in Blood Circulation in Patients Undergoing Radical Operation for colon Cancer. Chin. J. Anesthesiology.
32, 1165–1168. </Citation>
        </Reference>
        <Reference>
          <Citation>
Lindgren B. R., Grundström N., Andersson R. G. (1987). Comparison of the Effects of Clonidine and Guanfacine on the Histamine Liberation from Human Mast Cells and Basophils and on the Human Bronchial Smooth Muscle Activity. Arzneimittelforschung
37, 551–553. </Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2441713</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Liu Y., Liu W., Wang X., Wan Z., Liu Y., Leng Y. (2018). Dexmedetomidine Relieves Acute Inflammatory Visceral Pain in Rats through the ERK Pathway, Toll-like Receptor Signaling, and TRPV1 Channel. J. Mol. Neurosci.
66, 279–290. 10.1007/s12031-018-1172-5
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12031-018-1172-5</ArticleId>
            <ArticleId IdType="pubmed">30259406</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Lorton D., Bellinger Denise. L. (2015). Molecular Mechanisms Underlying β-adrenergic Receptor-Mediated Cross-Talk between Sympathetic Neurons and Immune Cells. Int. J. Mol. Sci.
16, 5635–5665. 10.3390/ijms16035635
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms16035635</ArticleId>
            <ArticleId IdType="pmc">PMC4394497</ArticleId>
            <ArticleId IdType="pubmed">25768345</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Ma X. D., Li B. P., Wang D. L., Yang W. S. (2017). Postoperative Benefits of Dexmedetomidine Combined with Flurbiprofen Axetil after Thyroid Surgery. Exp. Ther. Med.
14, 2148–2152. 10.3892/etm.2017.4717
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3892/etm.2017.4717</ArticleId>
            <ArticleId IdType="pmc">PMC5609191</ArticleId>
            <ArticleId IdType="pubmed">28962135</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
MacMicking J., Xie Q. W., Nathan C. (1997). Nitric Oxide and Macrophage Function. Annu. Rev. Immunol.
15, 323–350. 10.1146/annurev.immunol.15.1.323
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1146/annurev.immunol.15.1.323</ArticleId>
            <ArticleId IdType="pubmed">9143691</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Martinez Fernando. O., Gordon S. (2014). The M1 and M2 Paradigm of Macrophage Activation: Time for Reassessment. F1000prime Rep.
6, 13. 10.12703/P6-13
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.12703/P6-13</ArticleId>
            <ArticleId IdType="pmc">PMC3944738</ArticleId>
            <ArticleId IdType="pubmed">24669294</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Matsumoto Y. (2009). Park Il-Kwon., Kohyama KunikoMatrix Metalloproteinase (MMP)-9, but Not MMP-2, Is Involved in the Development and Progression of C Protein-Induced Myocarditis and Subsequent Dilated Cardiomyopathy. J. Immunol.
183, 4773–4781. 10.4049/jimmunol.0900871
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4049/jimmunol.0900871</ArticleId>
            <ArticleId IdType="pubmed">19734212</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Mikawa K., Akamatsu H., Nishina K., Shiga M., Maekawa N., Obara H., et al.  (1998). Propofol Inhibits Human Neutrophil Functions. Anesth. Analg.
87, 695–700. 10.1097/00000539-199809000-00039
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/00000539-199809000-00039</ArticleId>
            <ArticleId IdType="pubmed">9728856</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Miles B. A., Lafuse W. P., Zwilling B. S. (1996). Binding of Alpha-Adrenergic Receptors Stimulates the Anti-mycobacterial Activity of Murine Peritoneal Macrophages. J. Neuroimmunol.
71, 19–24. 10.1016/s0165-5728(96)00113-0
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s0165-5728(96)00113-0</ArticleId>
            <ArticleId IdType="pubmed">8982098</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Monneret G., Lepape A., Voirin N., Bohé J., Venet F., Debard A. L., et al.  (2006). Persisting Low Monocyte Human Leukocyte Antigen-DR Expression Predicts Mortality in Septic Shock. Intensive Care Med.
32, 1175–1183. 10.1007/s00134-006-0204-8
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00134-006-0204-8</ArticleId>
            <ArticleId IdType="pubmed">16741700</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Nishina K., Akamatsu H., Mikawa K., Shiga M., Maekawa N., Obara H., et al.  (1998). The Inhibitory Effects of Thiopental, Midazolam, and Ketamine on Human Neutrophil Functions. Anesth. Analg.
86, 159–165. 10.1097/00000539-199801000-00032
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/00000539-199801000-00032</ArticleId>
            <ArticleId IdType="pubmed">9428872</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Nishina K., Akamatsu H., Mikawa K. (1999). The Effects of Clonidine and Dexmedetomidine on Human Neutrophil Functions. Anesth. Analg.
88, 452–458. 10.1097/00000539-199902000-00042
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/00000539-199902000-00042</ArticleId>
            <ArticleId IdType="pubmed">9972773</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Ohmori Y., Hamilton T. A. (1994). Regulation of Macrophage Gene Expression by T-Cell-Derived Lymphokines. Pharmacol. Ther.
63, 235–264. 10.1016/0163-7258(94)90026-4
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0163-7258(94)90026-4</ArticleId>
            <ArticleId IdType="pubmed">7831392</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Panosian J. O., Marinetti G. V. (1983). Alpha 2-Adrenergic Receptors in Human Polymorphonuclear Leukocyte Membranes. Biochem. Pharmacol.
32, 2243–2247. 10.1016/0006-2952(83)90233-2
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0006-2952(83)90233-2</ArticleId>
            <ArticleId IdType="pubmed">6307315</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Park H., Li Z., Yang X. O., Chang S. H., Nurieva R., Wang Y. H., et al.  (2005). A Distinct Lineage of CD4 T Cells Regulates Tissue Inflammation by Producing Interleukin 17. Nat. Immunol.
6, 1133–1141. 10.1038/ni1261
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ni1261</ArticleId>
            <ArticleId IdType="pmc">PMC1618871</ArticleId>
            <ArticleId IdType="pubmed">16200068</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Piazza O., Staiano R. I., De Robertis. E., Conti G., Di Crescenzo. V., Loffredo S., et al.  (2016). Effect of α2-Adrenergic Agonists and Antagonists on Cytokine Release from Human Lung Macrophages Cultured In Vitro
. Transl. Med. Unisa.
15, 67–73. </Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5120752</ArticleId>
            <ArticleId IdType="pubmed">27896229</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Pilla L., Squarcina P., Coppa J., Mazzaferro V., Huber V., Pende D., et al.  (2005). Natural Killer and NK-like T-Cell Activation in Colorectal Carcinoma Patients Treated with Autologous Tumor-Derived Heat Shock Protein 96. Cancer Res.
65, 3942–3949. 10.1158/0008-5472.CAN-04-3493
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/0008-5472.CAN-04-3493</ArticleId>
            <ArticleId IdType="pubmed">15867395</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Prola A., Pires Da., Silva J., Guilbert A., Lecru L., Piquereau J., et al.  (2017). SIRT1 Protects the Heart from ER Stress-Induced Cell Death through eIF2α Deacetylation. Cell. Death Differ.
24, 343–356. 10.1038/cdd.2016.138
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/cdd.2016.138</ArticleId>
            <ArticleId IdType="pmc">PMC5299716</ArticleId>
            <ArticleId IdType="pubmed">27911441</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Raffaghello L., Bianchi G., Bertolotto M., Montecucco F., Busca A., Dallegri F., et al.  (2008). Human Mesenchymal Stem Cells Inhibit Neutrophil Apoptosis: a Model for Neutrophil Preservation in the Bone Marrow Niche. Stem Cell
26, 151–162. 10.1634/stemcells.2007-0416
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1634/stemcells.2007-0416</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Rezai H. R. (1968). Immunity to Intracellular Bacteria. Isr. J. Med. Sci.
4, 315–318. </Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">4870271</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Ribeiro M. C., Peruchetti D. B., Silva L. S., Silva-Filho J. L., Souza M. C., Henriques M. D. G., et al.  (2018). LPS Induces mTORC1 and mTORC2 Activation during Monocyte Adhesion. Front. Mol. Biosci.
5, 67. 10.3389/fmolb.2018.00067
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fmolb.2018.00067</ArticleId>
            <ArticleId IdType="pmc">PMC6058081</ArticleId>
            <ArticleId IdType="pubmed">30073169</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Scanzano A., Marco. C. (2015). Adrenergic Regulation of Innate Immunity: a Review. Front. Pharmacol.
6, 171. 10.3389/fphar.2015.00171
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fphar.2015.00171</ArticleId>
            <ArticleId IdType="pmc">PMC4534859</ArticleId>
            <ArticleId IdType="pubmed">26321956</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Schmitt F. C. F., Lipinski A., Hofer S., Uhle F., Nusshag C., Hackert T., et al.  (2020). Pulmonary Microbiome Patterns Correlate with the Course of the Disease in Patients with Sepsis-Induced ARDS Following Major Abdominal Surgery. J. Hosp. Infect.
S0195-6701 (20), 30203–30206. 10.1016/j.jhin.2020.04.028
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jhin.2020.04.028</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Sharma D., Farrar J. D. (2020). Adrenergic Regulation of Immune Cell Function and Inflammation. Semin. Immunopathol.
42, 709–717. 10.1007/s00281-020-00829-6
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00281-020-00829-6</ArticleId>
            <ArticleId IdType="pmc">PMC7678770</ArticleId>
            <ArticleId IdType="pubmed">33219396</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Shi W., Zhang P. (2019). Effect of Dexmedetomidine Combined with Lumbar Anesthesia on Th1/Th2 in Maternal Patients and Neonates Undergoing Caesarean Section. Exp. Ther. Med.
18 (2), 1426–1432. 10.3892/etm.2019.7648
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3892/etm.2019.7648</ArticleId>
            <ArticleId IdType="pmc">PMC6601378</ArticleId>
            <ArticleId IdType="pubmed">31316629</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Shin S., Kim K. J., Hwang H. J., Noh S., Oh J. E., Yoo Y. C. (2021). Immunomodulatory Effects of Perioperative Dexmedetomidine in Ovarian Cancer: An In Vitro and Xenograft Mouse Model Study. Front. Oncol.
11, 722743. 10.3389/fonc.2021.722743
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fonc.2021.722743</ArticleId>
            <ArticleId IdType="pmc">PMC8529066</ArticleId>
            <ArticleId IdType="pubmed">34692497</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Sikorski K., Chmielewski S., Przybyl L., Heemann U., Wesoly J., Baumann M., et al.  (2011). STAT1-mediated Signal Integration between IFNγ and LPS Leads to Increased EC and SMC Activation and Monocyte Adhesion. Am. J. Physiol. Cell. Physiol.
300 (6), C1337–C1344. 10.1152/ajpcell.00276.2010
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpcell.00276.2010</ArticleId>
            <ArticleId IdType="pubmed">21346151</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Singh R., Aggarwal A., Misra R. (2007). Th1/Th17 Cytokine Profiles in Patients with Reactive Arthritis/undifferentiated Spondyloarthropathy. J. Rheumatol.
34, 2285–2290. </Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17937463</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Song Q., Lin L., Chen L., Cheng L., Zhong W. (2020). Co-administration of N-Acetylcysteine and Dexmedetomidine Plays a Synergistic Effect on protection of LPS-Induced Acute Lung Injury via Correcting Th1/Th2/Th17 Cytokines Imbalance. Clin. Exp. Pharmacol. Physiol.
47, 294–301. 10.1111/1440-1681.13196
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/1440-1681.13196</ArticleId>
            <ArticleId IdType="pubmed">31631367</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Song X., Gao H., Qian Y. (2014). Th17 Differentiation and Their Pro-inflammation Function. Adv. Exp. Med. Biol.
841, 99–151. 10.1007/978-94-017-9487-9_5
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/978-94-017-9487-9_5</ArticleId>
            <ArticleId IdType="pubmed">25261206</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Stevenson G. W., Hall S. C., Rudnick S., Seleny F. L., Stevenson H. C. (1990). The Effect of Anesthetic Agents on the Human Immune Response. Anesthesiology
72, 542–552. 10.1097/00000542-199003000-00024
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/00000542-199003000-00024</ArticleId>
            <ArticleId IdType="pubmed">2178494</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Sugimoto M. A., Ribeiro A. L. C., Costa B. R. C., Vago J. P., Lima K. M., Carneiro F. S., et al.  (2017). Plasmin and Plasminogen Induce Macrophage Reprogramming and Regulate Key Steps of Inflammation Resolution via Annexin A1. Blood
129, 2896–2907. 10.1182/blood-2016-09-742825
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1182/blood-2016-09-742825</ArticleId>
            <ArticleId IdType="pmc">PMC5445571</ArticleId>
            <ArticleId IdType="pubmed">28320709</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Taniguchi T., Kidani Y., Kanakura H., Takemoto Y., Yamamoto K. (2004). Effects of Dexmedetomidine on Mortality Rate and Inflammatory Responses to Endotoxin-Induced Shock in Rats. Crit. Care Med.
32, 1322–1326. 10.1097/01.ccm.0000128579.84228.2a
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/01.ccm.0000128579.84228.2a</ArticleId>
            <ArticleId IdType="pubmed">15187514</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Theoharides T. C., Alysandratos K. D., Angelidou A., Delivanis D. A., Sismanopoulos N., Zhang B., et al.  (2012). Mast Cells and Inflammation. Biochim. Biophys. Acta
1822, 21–33. 10.1016/j.bbadis.2010.12.014
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbadis.2010.12.014</ArticleId>
            <ArticleId IdType="pmc">PMC3318920</ArticleId>
            <ArticleId IdType="pubmed">21185371</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Tian H., Hou L., Xiong Y., Cheng Q., Huang J. (2019). Effect of Dexmedetomidine-Mediated Insulin-like Growth Factor 2 (IGF2) Signal Pathway on Immune Function and Invasion and Migration of Cancer Cells in Rats with Ovarian Cancer. Med. Sci. Monit.
25, 4655–4664. 10.12659/MSM.915503
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.12659/MSM.915503</ArticleId>
            <ArticleId IdType="pmc">PMC6604677</ArticleId>
            <ArticleId IdType="pubmed">31230061</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Tippimanchai D. D., Nolan K., Poczobutt J., Verzosa G., Li H., Scarborough H., et al.  (2018). Adenoviral Vectors Transduce Alveolar Macrophages in Lung Cancer Models. Oncoimmunology
7, e1438105. 10.1080/2162402X.2018.1438105
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/2162402X.2018.1438105</ArticleId>
            <ArticleId IdType="pmc">PMC5980415</ArticleId>
            <ArticleId IdType="pubmed">29872579</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Tüfek A., Kaya S., Tokgöz O., Firat U., Evliyaoğlu O., Çelik F., et al.  (2013). The Protective Effect of Dexmedetomidine on Bupivacaine-Induced Sciatic Nerve Inflammation Is Mediated by Mast Cells. Clin. Invest. Med.
36, E95–E102. </Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23544611</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Ueshima H., Inada T., Koh. S. (2013). Suppression of Phagosome Proteolysis and Matrigel Migration with the α2-adrenergic Receptor Agonist Dexmedetomidine in Murine Dendritic Cells. Immunopharmacol. Immunotoxicol.
35, 558–566. 10.3109/08923973.2013.822509
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3109/08923973.2013.822509</ArticleId>
            <ArticleId IdType="pubmed">23927488</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Wang C., Yuan W., Hu A., Lin J., Xia Z., Yang C. F., et al.  (2020). Dexmedetomidine Alleviated Sepsis-Induced Myocardial Ferroptosis and Septic Heart Injury. Mol. Med. Rep.
22, 175–184. 10.3892/mmr.2020.11114
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3892/mmr.2020.11114</ArticleId>
            <ArticleId IdType="pmc">PMC7248514</ArticleId>
            <ArticleId IdType="pubmed">32377745</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Wang K., Wu M., Xu J., Wu C., Zhang B., Wang G., et al.  (2019). Effects of Dexmedetomidine on Perioperative Stress, Inflammation, and Immune Function: Systematic Review and Meta-Analysis. Br. J. Anaesth.
123: 777–794. 10.1016/j.bja.2019.07.027
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bja.2019.07.027</ArticleId>
            <ArticleId IdType="pubmed">31668347</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Wang K., Li C. (2018). Effects of Dexmedetomidine on Inflammatory Factors, T Lymphocyte Subsets and Expression of NF-ᴋb in Peripheral Blood Mononuclear Cells in Patients Receiving Radical Surgery of colon Carcinoma. Oncol. Lett.
15, 7153–7157. 10.3892/ol.2018.8205
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3892/ol.2018.8205</ArticleId>
            <ArticleId IdType="pmc">PMC5920235</ArticleId>
            <ArticleId IdType="pubmed">29725437</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Wang Y., Mao X., Chen H., Feng J., Yan M., Wang Y., et al.  (2019). Dexmedetomidine Alleviates LPS-Induced Apoptosis and Inflammation in Macrophages by Eliminating Damaged Mitochondria via PINK1 Mediated Mitophagy. Int. Immunopharmacol.
73, 471–481. 10.1016/j.intimp.2019.05.027
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.intimp.2019.05.027</ArticleId>
            <ArticleId IdType="pubmed">31170676</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Wang Y., Xu X., Liu H., Ji F. (2015). Effects of Dexmedetomine on Patients Undergoing Radical Gastrectomy. J. Surg. Res.
194, 147–153. 10.1016/j.jss.2014.10.008
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jss.2014.10.008</ArticleId>
            <ArticleId IdType="pubmed">25456116</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Webster N. R., Galley H. F. (2009). Immunomodulation in the Critically Ill. Br. J. Anaesth.
103, 70–81. 10.1093/bja/aep128
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/bja/aep128</ArticleId>
            <ArticleId IdType="pmc">PMC8543369</ArticleId>
            <ArticleId IdType="pubmed">19474216</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Wilhelms S. B., Walther S. M., Sjöberg F., De Geer. L. (2020). Causes of Late Mortality Among ICU-Treated Patients with Sepsis. Acta Anaesthesiol. Scand.
64, 961–966. 10.1111/aas.13592
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/aas.13592</ArticleId>
            <ArticleId IdType="pubmed">32319686</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Wolf A. M., Wolf D., Steurer M., Gastl G., Gunsilius E., Grubeck-Loebenstein B. (2003). Increase of Regulatory T Cells in the Peripheral Blood of Cancer Patients. Clin. Cancer Res.
9 (2), 606–612. </Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12576425</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Wu L., Lv H., Luo W., Jin S., Hang Y. (2015). Effects of Dexmedetomidine on Cellular Immunity of Perioperative Period in Children with Brain Neoplasms. Int. J. Clin. Exp. Med.
8 (2), 2748–2753. </Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4402876</ArticleId>
            <ArticleId IdType="pubmed">25932229</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Wu L., Yan C., Czader M., Foreman O., Blum J. S., Kapur R., et al.  (2012). Inhibition of PPARγ in Myeloid-Lineage Cells Induces Systemic Inflammation, Immunosuppression, and Tumorigenesis. Blood
119, 115–126. 10.1182/blood-2011-06-363093
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1182/blood-2011-06-363093</ArticleId>
            <ArticleId IdType="pmc">PMC3251224</ArticleId>
            <ArticleId IdType="pubmed">22053106</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Wu P., Chen J., Chen J., Tao J., Wu S., Xu G., et al.  (2020). Trimethylamine N-Oxide Promotes apoE Mice Atherosclerosis by Inducing Vascular Endothelial Cell Pyroptosis via the SDHB/ROS Pathway. J. Cell. Physiol.
235, 6582–6591. 10.1002/jcp.29518
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jcp.29518</ArticleId>
            <ArticleId IdType="pubmed">32012263</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Wu R. S., Wu K. C., Huang C. C., Chiang Y. Y., Chen C. C., Liao C. L., et al.  (2015). Different Cellular Responses of Dexmedetomidine at Infected Site and Peripheral Blood of Emdotoxemic BALB/c Mice. Environ. Toxicol.
30, 1416–1422. 10.1002/tox.22011
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/tox.22011</ArticleId>
            <ArticleId IdType="pubmed">24910415</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Wu X. H., Cui F., Zhang C., Meng Z. T., Wang D. X., Ma J., et al.  (2016). Low-dose Dexmedetomidine Improves Sleep Quality Pattern in Elderly Patients after Noncardiac Surgery in the Intensive Care Unit: A Pilot Randomized Controlled Trial. Anesthesiology
125, 979–991. 10.1097/ALN.0000000000001325
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/ALN.0000000000001325</ArticleId>
            <ArticleId IdType="pubmed">27571256</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Xia M., Sui Z. (2009). Recent Developments in CCR2 Antagonists. Expert Opin. Ther. Pat.
19, 295–303. 10.1517/13543770902755129
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1517/13543770902755129</ArticleId>
            <ArticleId IdType="pubmed">19441905</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Xu H., Wang B. G. (2003). Advance in Researches about Operative Stress Responses. Forei. Med. Sci. (Anesthesio Resus).
24, 278–281. </Citation>
        </Reference>
        <Reference>
          <Citation>
Yang C-L., Pei-Shan T., Huang C-J. (2008). Effects of Dexmedetomidine on Regulating Pulmonary Inflammation in a Rat Model of Ventilator-Induced Lung Injury. Acta Anaesthesiol. Taiwan.
46, 151–159. 10.1016/S1875-4597(09)60002-3
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1875-4597(09)60002-3</ArticleId>
            <ArticleId IdType="pubmed">19097961</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Yang X. H., Bai Q., Lv M. M., Fu H. G., Dong T. L., Zhou Z. (2017). Effect of Dexmedetomidine on Immune Function of Patients Undergoing Radical Mastectomy: a Double Blind and Placebo Control Study. Eur. Rev. Med. Pharmacol. Sci.
21 (5), 1112–1116. </Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28338179</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Younan G. J., Heit Y. I., Dastouri P., Kekhia H., Xing W., Gurish M. F., et al.  (2011). Mast Cells Are Required in the Proliferation and Remodeling Phases of Microdeformational Wound Therapy. Plast. Reconstr. Surg.
128, 649e–658e. 10.1097/PRS.0b013e318230c55d
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/PRS.0b013e318230c55d</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Yuan H. X., Chen C. Y., Li Y. Q., Ning D. S., Li Y., Chen Y. T., et al.  (2020). Circulating Extracellular Vesicles from Patients with Valvular Heart Disease Induce Neutrophil Chemotaxis via FOXO3a and the Inhibiting Role of Dexmedetomidine. Am. J. Physiol. Endocrinol. Metab.
319, E217–E231. 10.1152/ajpendo.00062.2020
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpendo.00062.2020</ArticleId>
            <ArticleId IdType="pubmed">32516026</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Zhang Y., Jin L. J., Zhou X., Liu Y., Li Y., Wen L. Y. (2018b). Effect of Dexmedetomidine on Stress Reactions and Cellular Immune Function of Patients in Perioperative Period Following Radial Resection for Rectal Carcinoma. J. Biol. Regul. Homeost. Agents
32 (1), 139–145. </Citation>
        </Reference>
        <Reference>
          <Citation>
Zhang Y., Jia S., Gao T., Zhang R., Liu Z., Wang Y. (2018a). Dexmedetomidine Mitigate Acute Lung Injury by Inhibiting IL-17-induced Inflammatory Reaction. Immunobiology
223, 32–37. 10.1016/j.imbio.2017.10.017
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.imbio.2017.10.017</ArticleId>
            <ArticleId IdType="pubmed">29030006</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Zhang Y., Ma D., Zhang Y., Tian Y., Wang X., Qiao Y., et al.  (2011). The Imbalance of Th17/Treg in Patients with Uterine Cervical Cancer. Clin. Chim. Acta
412, 894–900. 10.1016/j.cca.2011.01.015
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cca.2011.01.015</ArticleId>
            <ArticleId IdType="pubmed">21255562</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Zhao L., Li Y. (2020). Application of Dexmedetomidine Combined with Sufentanil in colon Cancer Resection and its Effect on Immune and Coagulation Function of Patients. Oncol. Lett.
20 (2), 1288–1294. 10.3892/ol.2020.11643
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3892/ol.2020.11643</ArticleId>
            <ArticleId IdType="pmc">PMC7377205</ArticleId>
            <ArticleId IdType="pubmed">32724370</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Zhao. T., Liu. Z., Yu. A., Zhang. Z. (2013). Effects of Intraoperative Administration of Dexmedetomidine on the Percentage of T-Lymphocyte Subsets and Natural Killer Cells in Patients with Colorectal Cancer. Open. J. Anesthesiology.
3, 104–108. 10.4236/ojanes.2013.32026
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4236/ojanes.2013.32026</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Zheng L., Zhao J., Zheng L., Jing S., Wang X. (2020). Effect of Dexmedetomidine on Perioperative Stress Response and Immune Function in Patients with Tumors. Technol. Cancer Res. Treat.
19, 1533033820977542. 10.1177/1533033820977542
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/1533033820977542</ArticleId>
            <ArticleId IdType="pmc">PMC7768568</ArticleId>
            <ArticleId IdType="pubmed">33356966</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Zhou H., Lu J., Shen Y., Kang S., Zong Y. (2017). Effects of Dexmedetomidine on CD42a/CD14, HLADR/CD14 and Inflammatory Cytokine Levels in Patients Undergoing Multilevel Spinal Fusion. Clin. Neurol. Neurosurg.
160, 54–58. 10.1016/j.clineuro.2017.06.012
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.clineuro.2017.06.012</ArticleId>
            <ArticleId IdType="pubmed">28668524</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Zhou H., Sun J., Zhong W., Pan X., Liu C., Cheng F., et al.  (2020). Ddemedetomidine Preconditioning Alleviated Murine Liver Ischemia and Reperfusion Injury by Promoting Macrophage M2 Activation via PPARγ/STAT3 Signaling. Int. Immunopharmacol.
82, 106363. 10.1016/j.intimp.2020.106363
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.intimp.2020.106363</ArticleId>
            <ArticleId IdType="pubmed">32145512</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Zong S., Du J., Chen Y., Tao H. (2021). Application Effect of Dexmedetomidine Combined with Flurbiprofen Axetil and Flurbiprofen Axetil Monotherapy in Radical Operation of Lung Cancer and Evaluation of the Immune Function. J. BUON.
26 (4), 1432–1439. </Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">34565001</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
